UNSPSC 51241107: Dorzolamide

This classification denotes a carbonic anhydrase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9JDX055TW1. European Medicines Agency schedules Dorzolamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06374MIG. Dorzolamide generally arises in the molecular formula C10H16N2O4S3.

UNSPSC 51241107 Dorzolamide is a Commodity code for a specific topical ophthalmic pharmaceutical product used to treat elevated intraocular pressure in glaucoma and ocular hypertension patients. State and local governments procure dorzolamide primarily through health department pharmacy programs, correctional health services, and municipal or county clinic networks that serve indigent or uninsured populations. The product is purchased as a branded or generic formulation in eye-drop suspension, typically in bulk quantities for standardized formulary inclusion and distribution to eligible patient populations.

The recent-opportunities data provided does not include any state or local solicitations for dorzolamide or other products under this code. Without current RFP, RFQ, IFB, or ITB records, geographic concentration and issuing-body patterns cannot be established from recent activity. Procurement of dorzolamide at the state and local level is typically routine, handled through established pharmaceutical supply contracts or group purchasing organizations rather than competitive solicitation, which may explain the absence of recent notice-based opportunities in the dataset.